This is not surprising because memory impairment is the most common presenting clinical symptom of clinically diagnosed DLB (cDLB) patients (with confirmed abnormal dopamine transporter imaging) [49] and most of the DLB/AD + DLB cases were diagnosed as DAT, showing a low sensitivity of the clinical criteria, at least in this small series [50]. The gene discussed is SLC6A3; the disease is Lewy body dementia.